Schedule 13D ownership disclosure

GRAPHITE BIO INC

Security class unavailable · CUSIP: 38870X104

Event date: 2021-06-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
26.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-21-211911
Form type
SC 13D
Filer
LENZ Therapeutics, Inc.
CIK
CIK 1815776
Filed
Jul 09, 2021
Reporting period
Jun 29, 2021
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub